Clinical Trial Update: Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examines the immunological memory generated by pneumococcal vaccines PCV13 and PPV23 in HIV-infected adults. The current status of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)
• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Aghia Sophia Children's Hospital of Athens | Conditions: HIV Infection | Phase 4 | Status: UNKNOWN